Sales rise 6.10% to Rs 1280.39 crore
Net profit of Alembic Pharmaceuticals rose 11.46% to Rs 250.70 crore in the quarter ended March 2021 as against Rs 224.93 crore during the previous quarter ended March 2020. Sales rose 6.10% to Rs 1280.39 crore in the quarter ended March 2021 as against Rs 1206.83 crore during the previous quarter ended March 2020.For the full year,net profit rose 42.14% to Rs 1178.11 crore in the year ended March 2021 as against Rs 828.82 crore during the previous year ended March 2020. Sales rose 17.10% to Rs 5393.13 crore in the year ended March 2021 as against Rs 4605.75 crore during the previous year ended March 2020.
Click here to connect with us on WhatsApp
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales1280.391206.83 6 5393.134605.75 17 OPM %26.6927.14 -28.8826.55 - PBDT343.08320.66 7 1551.551200.79 29 PBT291.86276.52 6 1368.081043.47 31 NP250.70224.93 11 1178.11828.82 42
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
